Validation of the “Six-and-Twelve” Prognostic Score in Transarterial Chemoembolization–Treated Hepatocellular Carcinoma Patients

The “six-and-twelve” prognostic score was proposed recently to predict survival rate in patients with unresectable hepatocellular carcinoma (HCC) treated with transarterial chemoembolization (TACE). However, it has not been validated externally. We validated this score and previous prognostic scores...

Descripción completa

Detalles Bibliográficos
Autores principales: Kaewdech, Apichat, Sripongpun, Pimsiri, Cheewasereechon, Natcha, Jandee, Sawangpong, Chamroonkul, Naichaya, Piratvisuth, Teerha
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7899857/
https://www.ncbi.nlm.nih.gov/pubmed/33605612
http://dx.doi.org/10.14309/ctg.0000000000000310

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7899857/
https://www.ncbi.nlm.nih.gov/pubmed/33605612
http://dx.doi.org/10.14309/ctg.0000000000000310

Ejemplares similares